Bifunctional autolysin (Glucosaminidase domain) (Gmd)

The Bifunctional autolysin (specifically the Glucosaminidase domain, Gmd) is a critical cell-wall-associated enzyme in Staphylococcus aureus, often referred to as Atl or AtlA. It is synthesized as a large precursor that is proteolytically processed into two subunits: an amidase and the Gmd domain. Gmd functions as an endo-beta-N-acetylglucosaminidase, which is essential for the separation of daughter cells during bacterial division by cleaving the peptidoglycan backbone. Beyond its role in binary fission, Gmd is involved in biofilm formation, host cell adhesion, and immune evasion, making it a significant virulence factor. In the context of therapeutic development, Gmd is a primary target for passive and active immunization strategies against methicillin-resistant S. aureus (MRSA) infections, such as osteomyelitis and prosthetic joint infections. Neutralizing monoclonal antibodies, such as 1C11 and its humanized derivative TPH-101, target Gmd to inhibit its enzymatic activity. This inhibition prevents the separation of daughter cells, leading to the formation of large bacterial megaclusters that are more susceptible to opsonophagocytosis by host macrophages. Clinical studies have also identified anti-Gmd IgG levels as a potential biomarker for protective immunity and favorable outcomes in patients with staphylococcal bone infections.

Other names

Endo-beta-N-acetylglucosaminidaseAtl-GmdAtlA-GmdMajor autolysin Gmd subunitAutolysin A glucosaminidase

Neutralization of enzymatic activity to inhibit daughter cell separation, leading to bacterial megacluster formation and enhanced opsonophagocytosis; or binding to peptidoglycan substrate to block enzyme access.